These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7738956)
21. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease. de Romeuf C; Mazurier C Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782 [TBL] [Abstract][Full Text] [Related]
22. Von Willebrand factor antigen levels in Behçet disease. Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757 [TBL] [Abstract][Full Text] [Related]
23. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
24. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease. Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923 [TBL] [Abstract][Full Text] [Related]
25. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Giannini S; Mezzasoma AM; Leone M; Gresele P Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988 [TBL] [Abstract][Full Text] [Related]
26. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656 [TBL] [Abstract][Full Text] [Related]
27. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239 [TBL] [Abstract][Full Text] [Related]
28. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268 [TBL] [Abstract][Full Text] [Related]
29. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. Smith RL; Sundberg J; Shamiyah E; Dyer A; Pachman LM J Rheumatol; 2004 Aug; 31(8):1644-9. PubMed ID: 15290747 [TBL] [Abstract][Full Text] [Related]
30. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. Chan NN; Fuller JH; Rubens M; Colhoun HM Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448 [TBL] [Abstract][Full Text] [Related]
31. Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis. Elst EF; Klein M; de Jager W; Kamphuis S; Wedderburn LR; van der Zee R; Albani S; Kuis W; Prakken BJ Arthritis Rheum; 2008 Feb; 58(2):547-55. PubMed ID: 18240224 [TBL] [Abstract][Full Text] [Related]
32. Biological effects of a S/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand disease. Meriane F; Zerhouni L; Djeha N; Goudemand M; Mazurier C Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1023-9. PubMed ID: 8148475 [TBL] [Abstract][Full Text] [Related]
33. A new automated screening assay for the diagnosis of von Willebrand disease. Salem RO; Van Cott EM Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831 [TBL] [Abstract][Full Text] [Related]
34. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681 [TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome. van Genderen PJ; Boertjes RC; van Mourik JA Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633 [TBL] [Abstract][Full Text] [Related]
36. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis. Bloom BJ; Nelson SM; Eisenberg D; Alario AJ J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101 [TBL] [Abstract][Full Text] [Related]
37. Factor VIII related antigen and childhood rheumatic diseases. Bowyer SL; Ragsdale CG; Sullivan DB J Rheumatol; 1989 Aug; 16(8):1093-7. PubMed ID: 2585406 [TBL] [Abstract][Full Text] [Related]
38. [Studies on von Willebrand factor antigen in endothelial cells and sera of patients with connective tissue diseases]. Kida S Ryumachi; 1990 Feb; 30(1):17-25. PubMed ID: 1696033 [TBL] [Abstract][Full Text] [Related]
39. Study of subcutaneous fat in children with juvenile dermatomyositis. Verma S; Singh S; Bhalla AK; Khullar M Arthritis Rheum; 2006 Aug; 55(4):564-8. PubMed ID: 16874777 [TBL] [Abstract][Full Text] [Related]